Relative biological effectiveness of alpha-particle emitters in vivo at low doses

Roger Howell, M. T. Azure, V. R. Narra, D. V. Rao

Research output: Contribution to journalArticle

27 Scopus citations

Abstract

The therapeutic potential of radionuclides that emit α particles, as well as their associated health hazards, have attracted considerable attention. The 224Ra daughters 212Pb and 212Bi, by virtue of their radiation properties which involve emission of α and β particles in their decay to stable 208Pb, have been proposed as candidates for radioimmunotherapy. Using mouse testes as the experimental model and testicular spermhead survival as the biological end point, the present work examines the radiotoxicity of 212Pb and its daughters. When 212Pb, in equilibrium with its daughters 212Bi, 212Po and 208Tl, was administered directly into the testis, the dose required to achieve 37% survival (D37) was 0.143 ± 0.014 Gy and the corresponding RBE of the mixed radiation field was 4.7 when compared to the D37 for acute external 120 kVp X rays. This datum, in conjunction with our earlier results for 210Po, was used to obtain an RBE- LET relationship for α particles emitted by tissue-incorporated radionuclides: RBE(α) = 4.8 - 6.1 x 10-2 LET + 1.0 x 10-3 LET2. Similarly, the dependence of RBE on α-particle energy E(α) was given by RBE(α) = 22 E(α)/-0.73. These relationships, based on in vivo experimental data, may be valuable in predicting biological effects of α- particle emitters.

Original languageEnglish (US)
Pages (from-to)352-360
Number of pages9
JournalRadiation Research
Volume137
Issue number3
DOIs
StatePublished - Jan 1 1994

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Radiation
  • Radiology Nuclear Medicine and imaging

Cite this